Online inquiry

IVTScrip™ mRNA-Human ARL17A, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK27438MR)

This product GTTS-WK27438MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ARL17A protein. This product can be used in SLC16A7+ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001113738.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51326
UniProt ID Q8IVW1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL17A, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK27438MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK26908MR IVTScrip™ mRNA-Human ASF1A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASF1A
GTTS-WK28648MR IVTScrip™ mRNA-Human ARL6IP4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL6IP4
GTTS-WK19699MR IVTScrip™ mRNA-Human ANKRD12, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD12
GTTS-WK23243MR IVTScrip™ mRNA-Human ARL4D, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARL4D
GTTS-WK8982MR IVTScrip™ mRNA-Human AFF1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AFF1
GTTS-WK27449MR IVTScrip™ mRNA-Human ARL6IP5, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARL6IP5
GTTS-WK19767MR IVTScrip™ mRNA-Human ANXA8L1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANXA8L1
GTTS-WK27145MR IVTScrip™ mRNA-Human ARL5B, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARL5B
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW